Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
Cancer HealthCast: This Unique Network Closes Research Gaps in Cancer Genomics
Dr. Leah Mechanic, Program Director at NCI and Dr. Bettina Drake, Professor at Washington University School of Medicine
24m listen -
HealthCast: Indian Health Service's Modernization Journey Means Replacing HHS’s Oldest Legacy System
Indian Health Service CIO Mitchell Thornbrugh joins HealthCast to talk about ways that IHS is progressing in its modernization program and the need for a patient-centered, human-centered approach to care.
26m listen -
CyberCast: CISA Task Force Prioritizes Managing Critical Infrastructure Risks, Countering Future Threats
The National Risk Management Center creates a unique task force designed to mitigate supply chain vulnerabilities, identify emerging threats and boost resiliency.
26m listen -
DOD Tackles Talent Management for the AI Age
Angela Cough, Chief of Digital Talent Management Office, DOD CDAO
28m listen